LUMOS PHARMA INC. - C
4.3000
27-11月-24 16:45:00
15 分の遅延
株式
-0.0200
-0.46%
本日の幅
4.3000 - 4.3400
ISIN
N/A
ソース
NASDAQ
-
Lumos Pharma to Participate in Upcoming Investor Conferences
10 3 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
Lumos Pharma to Report Full Year 2021 Financial Results and Host Conference Call on March 10, 2022
23 2 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
05 1 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in Upcoming Investor Conferences
10 11 2021 17:06:38 提供 Nasdaq GlobeNewswire
-
Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
03 11 2021 16:01:01 提供 Nasdaq GlobeNewswire
-
21 10 2021 16:05:01 提供 Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in September Investor Conferences
02 9 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
05 8 2021 08:00:02 提供 Nasdaq GlobeNewswire
-
03 8 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
02 8 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
22 7 2021 08:00:04 提供 Nasdaq GlobeNewswire
-
Lumos Pharma Announces Clinical Updates
20 7 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment
28 6 2021 08:00:00 提供 Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the Jefferies Virtual Healthcare Conference
19 5 2021 09:00:02 提供 Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the Oppenheimer Rare & Orphan Disease Summit
13 5 2021 09:00:01 提供 Nasdaq GlobeNewswire
-
05 5 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Lumos Pharma to Report First Quarter 2021 Financial Results and Host Conference Call on May 5, 2021
28 4 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
27 4 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
20 4 2021 16:05:00 提供 Nasdaq GlobeNewswire